What clinical trials are currently recruiting in Connecticut?

TrialFinder lists 1248 recruiting clinical trials with sites in or near Connecticut. Results cover a wide range of conditions and are updated regularly from ClinicalTrials.gov.

Do I need insurance to join a clinical trial in Connecticut?

No. Study-related care is covered by the trial sponsor at no cost to participants. This includes the experimental treatment, required lab tests, and study visits. Many trials also provide compensation for time and travel. Health insurance is not required to search or enroll.

What conditions have clinical trials recruiting in Connecticut?

Trials in Connecticut cover a broad range of conditions including cancer, diabetes, heart disease, neurological disorders, autoimmune diseases, mental health conditions, and more. Use TrialFinder to search by specific condition and location.

How do I sign up for a clinical trial in Connecticut?

Find a trial that matches your condition on TrialFinder, review the eligibility criteria, and contact the research site listed on the trial detail page. Most research teams will conduct a brief phone pre-screening before any in-person visit. You can also create a free TrialFinder profile to get matched to recruiting trials near you.

1248 Recruiting Trials

Clinical Trials in Connecticut

Browse 1248 recruiting clinical trials currently enrolling participants in Connecticut. Search by condition to find trials you may qualify for — at no cost.

Showing 15 of 1248 recruiting trials in Connecticut

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8

Recruiting

A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

PHASE1 Costa Mesa, California +4 sites · Advanced Liver Cancers

Recruiting

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

PHASE3 Birmingham, Alabama +4 sites · Pediatric Migraine

Recruiting

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

PHASE3 Scottsdale, Arizona +4 sites · Acute Treatment of Migraine

Recruiting

A Study to Test the Efficacy and Safety of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures

PHASE3 Phoenix, Arizona +4 sites · Stereotypical Prolonged Seizures

Recruiting

CRUSH PAD: Real-world Outcomes Following Use of Shockwave Intravascular Lithotripsy (IVL) Technology in Calcified Common Femoral Lesions

N/A New Haven, Connecticut +1 sites · Peripheral Arterial Disease, Critical Limb Ischemia

Recruiting

Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma

PHASE3 Birmingham, Alabama +4 sites · Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma

Recruiting

Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder

PHASE3 Dothan, Alabama +4 sites · Schizophrenia, Bipolar I Disorder

Recruiting

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial

PHASE2 Los Angeles, California +4 sites · Advanced Soft Tissue Sarcoma, Advanced Alveolar Soft Part Sarcoma

Recruiting

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

PHASE2 Birmingham, Alabama +4 sites · Acute Myeloid Leukemia, Myelodysplastic Syndrome

Recruiting

A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab

PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8

Recruiting

Alleviant ALLAY-HF Study

NA Phoenix, Arizona +4 sites · Heart Failure

Recruiting

A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis

PHASE2 Birmingham, Alabama +4 sites · Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis

Recruiting

Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before Surgery

PHASE2 Irvine, California +4 sites · Resectable Intrahepatic Cholangiocarcinoma

Recruiting

A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian Cancer

PHASE3 Phoenix, Arizona +4 sites · Low Grade Serous Ovarian Cancer

Recruiting

See all 1248 results in Connecticut

Check Your Eligibility

Create a free profile and our AI will match you to trials in Connecticut you may qualify for.

Get Matched — Free

No insurance required

Search by Condition in Connecticut

Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19

Browse Other States

California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon